BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 28468637)

  • 1. Drug-transporter mediated interactions between anthelminthic and antiretroviral drugs across the Caco-2 cell monolayers.
    Kigen G; Edwards G
    BMC Pharmacol Toxicol; 2017 May; 18(1):20. PubMed ID: 28468637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transport characteristics of peptidomimetics. Effect of the pyrrolinone bioisostere on transport across Caco-2 cell monolayers.
    Sudoh M; Pauletti GM; Yao W; Moser W; Yokoyama A; Pasternak A; Sprengeler PA; Smith AB; Hirschmann R; Borchardt RT
    Pharm Res; 1998 May; 15(5):719-25. PubMed ID: 9619780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carrier mechanisms involved in the transepithelial transport of bis(POM)-PMEA and its metabolites across Caco-2 monolayers.
    Annaert P; Van Gelder J; Naesens L; De Clercq E; Van den Mooter G; Kinget R; Augustijns P
    Pharm Res; 1998 Aug; 15(8):1168-73. PubMed ID: 9706045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and characterization of Caco-2 subclones expressing high levels of multidrug resistance protein efflux transporter.
    Horie K; Tang F; Borchardt RT
    Pharm Res; 2003 Feb; 20(2):161-8. PubMed ID: 12636153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Absorption and transport of isoflavonoid compounds from Tongmai formula across human intestinal epithelial (Caco-2) cells in vitro].
    Wang FR; Yang XW
    Zhongguo Zhong Yao Za Zhi; 2017 Aug; 42(16):3206-3212. PubMed ID: 29171242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the efflux transporter(s) responsible for restricting intestinal mucosa permeation of the coumarinic acid-based cyclic prodrug of the opioid peptide DADLE.
    Tang F; Borchardt RT
    Pharm Res; 2002 Jun; 19(6):787-93. PubMed ID: 12134948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the regional intestinal kinetics of drug efflux in rat and human intestine and in Caco-2 cells.
    Makhey VD; Guo A; Norris DA; Hu P; Yan J; Sinko PJ
    Pharm Res; 1998 Aug; 15(8):1160-7. PubMed ID: 9706044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors.
    Profit L; Eagling VA; Back DJ
    AIDS; 1999 Sep; 13(13):1623-7. PubMed ID: 10509562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the efflux transporter(s) responsible for restricting intestinal mucosa permeation of an acyloxyalkoxy-based cyclic prodrug of the opioid peptide DADLE.
    Tang F; Borchardt RT
    Pharm Res; 2002 Jun; 19(6):780-6. PubMed ID: 12134947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereoselective transport and uptake of propranolol across human intestinal Caco-2 cell monolayers.
    Wang Y; Cao J; Wang X; Zeng S
    Chirality; 2010 Mar; 22(3):361-8. PubMed ID: 19575464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transepithelial transport of artepillin C in intestinal Caco-2 cell monolayers.
    Konishi Y
    Biochim Biophys Acta; 2005 Jul; 1713(2):138-44. PubMed ID: 16004960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic roles of neutral surfactants on concurrent polarized and passive membrane transport of a model peptide in Caco-2 cells.
    Nerurkar MM; Ho NF; Burton PS; Vidmar TJ; Borchardt RT
    J Pharm Sci; 1997 Jul; 86(7):813-21. PubMed ID: 9232522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transport characteristics of tryptanthrin and its inhibitory effect on P-gp and MRP2 in Caco-2 cells.
    Zhu X; Zhang X; Ma G; Yan J; Wang H; Yang Q
    J Pharm Pharm Sci; 2011; 14(3):325-35. PubMed ID: 21824448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The H2 receptor antagonist nizatidine is a P-glycoprotein substrate: characterization of its intestinal epithelial cell efflux transport.
    Dahan A; Sabit H; Amidon GL
    AAPS J; 2009 Jun; 11(2):205-13. PubMed ID: 19319690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretory transport of ranitidine and famotidine across Caco-2 cell monolayers.
    Lee K; Ng C; Brouwer KL; Thakker DR
    J Pharmacol Exp Ther; 2002 Nov; 303(2):574-80. PubMed ID: 12388638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcellular and lipophilic complex-enhanced intestinal absorption of human growth hormone.
    Wu SJ; Robinson JR
    Pharm Res; 1999 Aug; 16(8):1266-72. PubMed ID: 10468030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular Uptake and Transport Characteristics of FL118 Derivatives in Caco-2 Cell Monolayers.
    Zhou Y; Hu W; Zhang X; Wang Y; Zhuang W; Li F; Li Q
    Chem Pharm Bull (Tokyo); 2021; 69(11):1054-1060. PubMed ID: 34719586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transport of thalidomide by the human intestinal caco-2 monolayers.
    Zhou S; Li Y; Kestell P; Schafer P; Chan E; Paxton JW
    Eur J Drug Metab Pharmacokinet; 2005; 30(1-2):49-61. PubMed ID: 16010862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRP2 mediated drug-drug interaction: indomethacin increases sulfasalazine absorption in the small intestine, potentially decreasing its colonic targeting.
    Dahan A; Amidon GL
    Int J Pharm; 2010 Feb; 386(1-2):216-20. PubMed ID: 19944137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleobase- and p-glycoprotein-mediated transport of AG337 in a Caco-2 cell culture model.
    Hu M; Chen J
    Mol Pharm; 2004; 1(3):194-200. PubMed ID: 15981922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.